About This Event

Apogee Therapeutics (Nasdaq: APGE), a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis, chronic obstructive pulmonary disease, and related inflammatory and immunology indications with high unmet need, visits the Nasdaq MarketSite in Times Square.

In honor of the occasion, Michael Henderson, Chief Executive Officer of Apogee Therapeutics, rings the Closing Bell.